5 Results for "

human TGR5

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "human TGR5" in MCE Product Catalog:

Cat. No.: HY-120565
CAS No.: 1594041-84-5
WB403 is an orally active TGR5 activator with an EC50 of 5.5 μM against human TGR5. WB403 activates TGR5 to stimulate downstream signaling pathways, promote GLP-1 secretion, improve glucose tolerance in mice with type 2 diabetes, and reduce levels of fasting blood glucose, postprandial blood glucose and HbA1c. WB403 increases pancreatic β-cell mass and restores the distribution of α-cells and β-cells in islets. WB403 is applicable to the research of type 2 diabetes .
loading...
    loading...
Cat. No.: HY-182905
CAS No.: 3069267-46-2
SSTR5/TGR5-modulator-1 is an orally active and dual-target small molecule, balanced in vitro activity at human TGR5 and human SSTR5. SSTR5/TGR5-modulator-1 activates human TGR5 to promote cAMP accumulation. SSTR5/TGR5-modulator-1 blocks human SSTR5 to inhibit agonist-induced calcium mobilization. SSTR5/TGR5-modulator-1 improves glucose tolerance in mice. SSTR5/TGR5-modulator-1 alleviates gallbladder filling in mice at pharmacologically relevant doses. SSTR5/TGR5-modulator-1 has suboptimal physicochemical and metabolic properties.SSTR5/TGR5-modulator-1 can be used for the research of type 2 diabetes mellitus .
loading...
    loading...
Cat. No.: HY-181102
CAS No.: 3081614-92-5
TGR5 agonist 10 is a selective, allosteric and orally active Takeda G protein coupled receptor 5 (TGR5) agonist with EC50s of 0.8 μM and 0.6 μM for human TGR5 and mouse TGR5, respectively. TGR5 agonist 10 demonstrates selectivity for TGR5 over FXR. TGR5 agonist 10 activates hTGR5 and mTGR5 to induce cAMP accumulation, and positively modulates lithocholic acid functional activity and potency at hTGR5, with higher selectivity for cAMP formation over β-arrestin2 recruitment. TGR5 agonist 10 exerts glucose-lowering effects in Mus musculus oral glucose tolerance tests. TGR5 agonist 10 can be used for the research of diabetes .
loading...
    loading...
Cat. No.: HY-183692
CAS No.: 3061938-00-6
FXR agonist 18 is an orally active FXR agonist, with an EC50 of 10 nM against human FXR and an EC50 of 1360 nM against human TGR5. FXR agonist 18 inhibits inflammatory responses by reducing nitrite production, downregulating the expression of pro-inflammatory genes (Tnf, Adgre1, Cyp8b1, upregulating the expression of FXR, Hmox1, Nqo1, Nrf2, and enhancing antioxidant responses. FXR agonist 18 ameliorates liver fibrosis in mice, exhibits protective effects in mice with cholestatic liver injury, and shows anti-MASH efficacy. FXR agonist 18 can be used in studies of metabolic dysfunction-associated steatohepatitis .
loading...
    loading...
Cat. No.: HY-P704194
Purity:  ≥ 85%, as determined by reducing SDS-PAGE.
Synonyms: GPBAR1; Membrane-Type Receptor For Bile Acids; G Protein-Coupled Bile Acid Receptor 1; G-Protein Coupled Receptor GPCR19; M-BAR; MGC40597; BG37; GPCR; TGR5; G-Protein Coupled Bile Acid Receptor BG37; GPCR19; Membrane Bile Acid Receptor; GPR131; HGPCR19; G
Species:  
Human
Source:  
E. coli Cell-free
loading...
    loading...